BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim NH, Kim HJ, Cho YK, Hong HP, Kim BI. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization. J Korean Med Sci 2019;34:e208. [PMID: 31373186 DOI: 10.3346/jkms.2019.34.e208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zeng J, Wang C, Wang Y, Luo Z, Zhang Y, Luo X. Sorafenib plus partial splenic embolism for treatment of hepatocellular carcinoma Barcelona stage C combined with hypersplenism: a case series. J Int Med Res 2021;49:3000605211023351. [PMID: 34139869 DOI: 10.1177/03000605211023351] [Reference Citation Analysis]
2 Liu J, Wu Z, Zhang J, Xie Y, Sun P, Wu H, Chang X, Zhang L, Liu F. Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism. Medicine 2021;100:e26441. [DOI: 10.1097/md.0000000000026441] [Reference Citation Analysis]